Coordinate regulation of gallbladder motor function in the gut-liver axis

Hepatology

Volumn 47, Issue 6, 2008, Pages 2112-2126

  Portincasa, Piero ^a   Di Ciaula, Agostino ^a   Wang, Helen H ^b   Palasciano, Giuseppe ^a   Van Erpecum, Karel J ^c   Moschetta, Antonio ^a,d   Wang, David Q H ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLECYSTOKININ; CHOLESTEROL; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 19; MUCIN;

BILE COMPOSITION; CHOLECYSTITIS; CHOLELITHIASIS; DISEASE ASSOCIATION; GALLBLADDER CONTRACTION; GALLBLADDER EPITHELIUM; GALLBLADDER FUNCTION; GALLBLADDER MOTILITY; GALLSTONE FORMATION; HORMONE RELEASE; HUMAN; IN VITRO STUDY; MOTOR PERFORMANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE RELAXATION; BILE; GALLBLADDER; GALLSTONE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; LIVER; PATHOPHYSIOLOGY; PHYSIOLOGY;

BILE; GALLBLADDER; GALLSTONES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; LIVER;

EID: 44849102561     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22204     Document Type: Review

References (216)

1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-239.
2. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. HEPATOLOGY 2002;35:1507-1512.
3. Portincasa P, Moschetta A, Petruzzelli M, Palasciano G, Di Ciaula A, Pezzolla A. Gallstone disease: Symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol 2006;20:1017-1029.
4. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-1511.
5. Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006;20:981-996.
6. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.
7. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 2004;80:1-2.
8. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, et al. Epidemiology of gallstone disease in Italy: prevalence data of the multicenter italian study on cholelithiasis (M.I.C.O.L.). Am J Epidemiol 1995;141:158-165.
9. Afdhal NH. Epidemiology, risk factors, and pathogenesis of gallstones. In: Afdahl NH, editor. Gallbladder and Biliary Tract Disease. New York, Basel: Marcel Dekker, Inc.; 2000:21-38.
10. Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007;27:109-121.
11. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. Oxford, UK: Blackwell Science, 2002.
12. van Erpecum KJ, Venneman NG, Portincasa P, vanBerge-Henegouwen GP. Review article: agents affecting gall-bladder motility-role in treatment and prevention of gallstones. Aliment Pharmacol Ther 2000;14(Suppl 2):66-70.
13. Portincasa P, Di Ciaula A, Baldassarre G, Palmieri VO, Gentile A, Cimmino A, et al. Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol 1994;21:430-440.
14. Stolk MF, van Erpecum KJ, Peeters TL, Samsom M, Smout AJ, Akkermans LM, et al. Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients. Dig Dis Sci 2001;46:1328-1334.
15. Choi M, Moschetta A, Bookout AL, Peng L, Umetani M, Holmstrom SR, et al. Identification of a hormonal basis for gallbladder filling. Nat Med 2006;12:1253-1255.
16. Niebergall-Roth E, Teyssen S, Singer MV. Neurohormonal control of gallbladder motility. Scand J Gastroenterol 1997;32:737-750.
17. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri VO, Moschetta A, vanBerge-Henegouwen GP, et al. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000;30:317-324.
18. Greaves RSH, O'Donnell LDJ. Gallbladder motility and gallstones. In: Afdhal NH, ed. Gallbladder and Biliary Tract Diseases. New York, NY: Marcel Dekker Inc.; 2000:275-295.
19. Masclee AAM, Jansen JB, Driessen WM, Geuskens LM, Lamers CBHW. Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients. Dig Dis Sci 1989;34:353-359.
20. Pauletzki JG, Cicala M, Holl J, Sauerbruch T, Schafmayer A, Paumgartner G. Correlation between gallbladder fasting volume and postprandial emptying in patients with gallstones and healthy controls. Gut 1993;34:1443-1447.
21. Stolk MFJ, van Erpecum KJ, Renooij W, Portincasa P, van de Heijning BJM, vanBerge-Henegouwen GP. Gallbladder emptying in vivo, bile composition and nucleation of cholesterol crystals in patients with cholesterol gallstones. Gastroenterology 1995;108:1882-1888.
22. van Erpecum KJ, vanBerge-Henegouwen GP, Stolk MFJ, Hopman WPM, Jansen JBMJ, Lamers CBHW. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. J Hepatol 1992;14:194-202.
23. Otsuki M. Pathophysiological role of cholecystokinin in humans. J Gastroenterol Hepatol 2000;15(Suppl):D71-D83.
24. Beglinger C, Hildebrand P, Adler G, Werth B, Harvey JR, Toouli J. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 1992;22:827-834.
25. Maselli MA, Piepoli AL, Pezzolla F, Guerra V, Caruso ML, Mennuni L, et al. Effect of three nonpeptide cholecystokinin antagonists on human isolated gallbladder. Dig Dis Sci 2001;46:2773-2778.
26. Portincasa P, vanBerge-Henegouwen GP. Gallbladder smooth muscle function and its dysfunction in cholesterol gallstone disease. In: Afdhal NH, ed. Gallbladder and Biliary Tract Diseases. New York, NY: Marcel Dekker Inc.; 2000:39-63.
27. Portincasa P, Di Ciaula A, vanBerge-Henegouwen GP. Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep 2004;6:151-162.
28. Schneider H, Sanger H, Hanisch E. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones. J Hepatol 1997;26:1063-1068.
29. Upp JR Jr, Nealon WH, Singh P, Fagan CJ, Jonas AS, Greeley GH Jr, et al. Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg 1987;205:641-648.
30. Zhu J, Han TQ, Chen S, Jiang Y, Zhang SD. Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients. World J Gastroenterol 2005;11:1685-1689.
31. Wang DQ, Schmitz F, Kopin AS, Carey MC. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 2004;114:521-528.
32. Miyasaka K, Takata Y, Funakoshi A. Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J Gastroenterol 2002;37(Suppl 14):102-106.
33. Ding X, Lu CY, Mei Y, Liu CA, Shi YJ. Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus. Hepatobiliary Pancreat Dis Int 2005;4:295-298.
34. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005;2:217-225.
35. Modica S, Moschetta A. Nuclear bile acid receptor FXR as pharmacological target: are we there yet? FEBS Lett 2006;580:5492-5499.
36. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6:517-526.
37. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000;6:507-515.
38. Sutherland SD. The neurons of the gallbladder and gut. J Anat 1967;101:701-709.
39. Mawe GM, Talmage EK, Cornbrooks EB, Gokin AP, Zhang L, Jennings LJ. Innervation of the gallbladder: structure, neurochemical coding, and physiological properties of guinea pig gallbladder ganglia. Microsc Res Tech 1997;39:1-13.
40. Stengel PW, Cohen ML. Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine- induced gallbladder contractility. J Pharmacol Exp Ther 2002;301:643-650.
41. Yegen B, Biren T, Onat F, Tankurt E, Gurmen N, Oktay S, et al. Modulation of gallbladder contraction by pirenzepine in humans. Am J Gastroenterol 1995;90:1489-1494.
42. Parkman HP, Garbarino R, Ryan JP. Myosin light chain phosphorylation correlates with contractile force in guinea pig gallbladder muscle. Dig Dis Sci 2001;46:176-181.
43. Burgstaller M, Barthel S, Kasper H. Diabetic gastroparesis and gallbladder disease. Ultrasound diagnosis after multiple-component meals. Dtsch Med Wochenschr 1992;117:1868-1873.
44. Catnach SM, Ballinger AB, Stevens M, Fairclough PD, Trembath RC, Drury PL, et al. Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy. Gut 1993;34:1123-1127.
45. Dilengite MA, Loria P, Menozzi D, Tripodi A, Guicciardi L, Digrisolo A, et al. Effect of diabetic autonomic neuropathy on gall bladder kinetics in insulin-dependent diabetic patients. Eur J Gastroenterol Hepatol 1994;6:765-771.
46. Fiorucci S, Bosso R, Scionti L, DiSanto S, Annibale B, Delle Fave G, et al. Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with of without autonomic neuropathy. Dig Dis Sci 1990;35:1089-1097.
47. Fiorucci S, Scionti L, Bosso R, Desando A, Bottini P, Marino C, et al. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci 1992;37:1671-1677.
48. Palasciano G, Portincasa P, Belfiore A, Baldassarre G, Cignarelli M, Paternostro A, et al. Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity. J Intern Med 1992;231:123-127.
49. Raman PG, Patel A, Mathew V. Gallbladder disorders and type 2 diabetes mellitus - a clinic-based study. J Assoc Physicians India 2002;50:887-890.
50. Shaw SJ, Hajnal F, Lebovitz Y, Ralls P, Bauer M, Valenzuela J, et al. Gallbladder dysfunction in diabetes mellitus. Dig Dis Sci 1993;38:490-496.
51. Stone BG, Gavaler JS, Belle SH, Shreiner DP, Charneau J, Sarva RP, et al. Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology 1988;95:170-176.
52. Altomare D, Pilot MA, Scott M, Williams N, Rubino M, Ilincic L, et al. Detection of subclinical autonomic neuropathy in constipated patients using a sweat test. Gut 1992;33:1539-1543.
53. Altomare DF, Portincasa P, Rinaldi M, Di Ciaula A, Martinelli E, Amoruso AC, et al. Slow-transit constipation: a solitary symptom of a systemic gastrointestinal disease. Dis Colon Rectum 1999;42:231-240.
54. Wedmann B, Pfaffenbach B, Wegener M. Does chronic alcohol drinking modify digestive gastrobiliary motility? Leber Magen Darm 1996;26:98-102.
55. Chaudhry V, Corse AM, O'Brian R, Cornblath DR, Klein AS, Thuluvath PJ. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. HEPATOLOGY 1999;29:1698-1703.
56. Oliver MI, Miralles R, Rubies-Prat J, Navarro X, Espadaler JM, Sola R, et al. Autonomic dysfunction in patients with non-alcoholic chronic liver disease. J Hepatol 1997;26:1242-1248.
57. Chawla A, Puthumana L, Thuluvath PJ. Autonomic dysfunction and cholelithiasis in patients with cirrhosis. Dig Dis Sci 2001;46:495-498.
58. Portincasa P, Moschetta A, Berardino M, Di Ciaula A, Vacca M, Baldassarre G, et al. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol 2004;10:2383-2390.
59. Carey MC. Pathogenesis of gallstones. Am J Surg 1993;165:410-419.
60. Trotman BW, Ostrow JD, Soloway RD. Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis 1974;19:585-590.
61. Everson GT, Nemeth A, Kourourian S, Zogg D, Leff NB, Dixon D, et al. Gallbladder function is altered in sickle hemoglobinopathy. Gastroenterology 1989;96:1307-1316.
62. Attili AF, Casale R, Di Lauro G, Festuccia V, Natali L, Pasqualetti P. Assessment of gallbladder motility in patients with alcoholic hepatic cirrhosis after a fatty meal. A real-time ultrasonography study. Minerva Gastroenterol Dietol 1992;38:45-48.
63. Li CP, Hwang SJ, Lee FY, Chang FY, Lin HC, Lu RH, et al. Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. Dig Dis Sci 2000;45:1109-1114.
64. Pompili M, Rapaccini GL, Caturelli E, Curro D, Montuschi P, D'Amato M, et al. Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis. Dig Dis Sci 1995;40:428-434.
65. Moschetta A, Stolk MF, Rehfeld JF, Portincasa P, Slee PH, Koppeschaar HP, et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther 2001;15:181-185.
66. Pereira SP, Hussaini SH, Murphy GM, Wass JA, Dowling RH. Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile. Aliment Pharmacol Ther 2001;15:1435-1443.
67. Ginanni Corradini S, Ripani C, Della Guardia P, Giovanelli L, Elisei W, Cantafora A, et al. The human gallbladder increases cholesterol solubility in bile by differential lipid absorption: a study using a new in vitro model of isolated intra-arterially perfused gallbladder. HEPATOLOGY 1998;28:314-322.
68. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989;97:1479-1484.
69. Chen Q, Amaral J, Biancani P, Behar J. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology 1999;116:678-685.
70. Ginanni Corradini S, Elisei W, Giovannelli L, Ripani C, Della GP, Corsi A, et al. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology 2000;118:912-920.
71. Lee J, Shirk A, Oram JF, Lee SP, Kuver R. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway. Biochem J 2002;364:475-484.
72. Hauser H, Dyer JH, Nandy A, Vega MA, Werder M, Bieliauskaite E, et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 1998;37:17843-17850.
73. Calvo D, Vega MA. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993;268:18929-18935.
74. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996;271:518-520.
75. Labonte ED, Howles PN, Granholm NA, Rojas JC, Davies JP, Ioannou YA, et al. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochim Biophys Acta 2007;1771:1132-1139.
76. Mardones P, Quinones V, Amigo L, Moreno M, Miquel JF, Schwarz M, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001;42:170-180.
77. Bietrix F, Yan D, Nauze M, Rolland C, Bertrand-Michel J, Comera C, et al. Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J Biol Chem 2006;281:7214-7219.
78. Johnson MS, Svensson PA, Boren J, Billig H, Carlsson LM, Carlsson B. Expression of scavenger receptor class B type I in gallbladder columnar epithelium. J Gastroenterol Hepatol 2002;17:713-720.
79. Miquel JF, Moreno M, Amigo L, Molina H, Mardones P, Wistuba II, et al. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut 2003;52:1017-1024.
80. Davies JP, Levy B, Ioannou YA. Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics 2000;65:137-145.
81. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004;303:1201-1204.
82. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 2007;117:1968-1978.
83. Spener F. Ezetimibe in search of receptor(s)-Still a never-ending challenge in cholesterol absorption and transport. Biochim Biophys Acta 2007;1771:1113-1116.
84. Yu L, Hammer RE, Li-Hawkins J, Von BK, Lutjohann D, Cohen JC, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 2002;99:16237-16242.
85. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002;110:671-680.
86. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000;290:1771-1775.
87. Tauscher A, Kuver R. ABCG5 and ABCG8 are expressed in gallbladder epithelial cells. Biochem Biophys Res Commun 2003;307:1021-1028.
88. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002;277:18793-18800.
89. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999;104:R25-R31.
90. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999;22:347-351.
91. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-345.
92. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999;22:352-355.
93. Erranz B, Miquel JF, Argraves WS, Barth JL, Pimentel F, Marzolo MP. Megalin and cubilin expression in gallbladder epithelium and regulation by bile acids. J Lipid Res 2004;45:2185-2198.
94. Hofmann AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 2007;6:15-27.
95. Chignard N, Mergey M, Veissiere D, Parc R, Capeau J, Poupon R, et al. Bile acid transport and regulating functions in the human biliary epithelium. HEPATOLOGY 2001;33:496-503.
96. Dray-Charier N, Paul A, Veissiere D, Mergey M, Scoazec JY, Capeau J, et al. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. Lab Invest 1995;73:828-836.
97. Scoazec JY, Bringuier AF, Medina JF, Martinez-Anso E, Veissiere D, Feldmann G, et al. The plasma membrane polarity of human biliary epithelial cells: in situ immunohistochemical analysis and functional implications. J Hepatol 1997;26:543-553.
98. Guarino MP, Cong P, Cicala M, Alloni R, Carotti S, Behar J. Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut 2007;56:815-820.
99. Xu QW, Shaffer EA. The potential site of impaired gallbladder contractility in an animal model of cholesterol gallstone disease. Gastroenterology 1996;110:251-257.
100. Amaral J, Xiao ZL, Chen Q, Yu P, Biancani P, Behar J. Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterology 2001;120:506-511.
101. Chen Q, Amaral J, Oh S, Biancani P, Behar J. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology 1997;113:930-937.
102. DeCarvalho S. Atherosclerosis. I. A leiomyoproliferative disease of the arteries resulting from the breakdown of the endotelial barrier to potent blood growth factors. Angiology 1995;36:497-710.
103. Behar J, Rhim BY, Thompson W, Biancani P. Inositol trisphosphate restores impaired human gallbladder motility associated with cholesterol stones. Gastroenterology 1993;104:563-568.
104. Chen Q, Yu P, De Petris G, Biancani P, Behar J. Distinct muscarinic receptors and signal transduction pathways in gallbladder muscle. J Pharmacol Exp Ther 1995;273:650-655.
105. Chen Q, De Petris G, Yu P, Amaral J, Biancani P, Behar J. Different pathways mediate cholecystokinin actions in cholelithiasis. Am J Physiol 1997;272:G838-G844.
106. Yu P, Chen Q, Xiao Z, Harnett K, Biancani P, Behar J. Signal transduction pathways mediating CCK-induced gallbladder muscle contraction. Am J Physiol 1998;275:G203-G211.
107. Jennings LJ, Xu QW, Firth TA, Nelson MT, Mawe GM. Cholesterol inhibits spontaneous action potentials and calcium currents in guinea pig gallbladder smooth muscle. Am J Physiol Gastrointest Liver Physiol 1999;277:G1017-G1026.
108. Stolk MFJ, van de Heijning BJM, van Erpecum KJ, Verheem A, Akkermans LMA, vanBerge-Henegouwen GP. Effect of bile salts on in vitro gallbladder motility: preliminary study. Ital J Gastroenterol Hepatol 1996;28:105-110.
109. Xu QW, Freedman SM, Shaffer EA. Inhibitory effect of bile salts on gallbladder smooth muscle contractility in the guinea pig in vitro. Gastroenterology 1997;112:1699-1706.
110. Xiao ZL, Rho AK, Biancani P, Behar J. Effecrs of bile acids on the muscle functions of guinea pig gallbladder. Am J Physiol Gastrointest Liver Physiol 2002;283:G87-G94.
111. van de Heijning BJM, van de Meeberg P, Portincasa P, Doornewaard H, Hoebers FJP, van Erpecum KJ, et al. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci 1999;44:190-196.
112. Dopico AM, Walsh JV Jr, Singer JJ. Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells. J Gen Physiol 2002;119:251-273.
113. Wang HH, Afdhal NH, Gendler SJ, Wang DQ. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology 2006;131:210-222.
114. Wang HH, Afdhal NH, Gendler SJ, Wang DQ. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation. J Lipid Res 2004;45:438-447.
115. Wilhelmi M, Jungst C, Mock M, Meyer G, Zundt B, Del Pozo R, et al. Effect of gallbladder mucin on the crystallization of cholesterol in bile. Eur J Gastroenterol Hepatol 2004;16:1301-1307.
116. Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. HEPATOLOGY 2005;41:1322-1328.
117. Brotschi EA, LaMorte WW, Williams LFJ. Effect of dietary cholesterol and indomethacin on cholelithiasis and gallbladder motility in guinea pig. Dig Dis Sci 1984;29:1050-1056.
118. Hemming JM, Guarraci FA, Firth TA, Jennings LJ, Nelson MT, Mawe GM. Actions of histamine on muscle and ganglia of the guinea pig gallbladder. Am J Physiol Gastrointest Liver Physiol 2000;279:G622-G630.
119. Jennings LJ, Salido GM, Pozo MJ, Davison JS, Sharkey KA, Lea RW, et al. The source and action of histamine in the isolated guinea-pig gallbladder. Inflamm Res 1995;44:447-453.
120. Martinez-Cuesta MA, Moreno L, Morillas J, Ponce J, Esplugues JV. Influence of cholecystitis state on pharmacological response to cholecystokinin of isolated human gallbladder with gallstones. Dig Dis Sci 2003;48:898-905.
121. O'Riordan AM, Quinn T, Baird AW. Role of prostaglandin E(2) and Ca(2+) in bradykinin induced contractions of guinea-pig gallbladder in vitro. Eur J Pharmacol 2001;431:245-252.
122. Trevisani M, Amadesi S, Schmidlin F, Poblete MT, Bardella E, Maggiore B, et al. Bradykinin B2 receptors mediate contraction in the normal and inflamed human gallbladder in vitro. Gastroenterology 2003;125:126-135.
123. Kano M, Shoda J, Satoh S, Kobayashi M, Matsuzaki Y, Abei M, et al. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin. J Lab Clin Med 2002;139:285-294.
124. van Erpecum KJ, Wang DQ, Moschetta A, Ferri D, Svelto M, Portincasa P, et al. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 2006;47:32-41.
125. Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004;10:1352-1358.
126. Greaves RR, O'Donnell LJ, Farthing MJ. Differential effect of prostaglandins on gallstone-free and gallstone-containing human gallbladder. Dig Dis Sci 2000;45:2376-2381.
127. Xiao ZL, Andrada MJ, Biancani P, Behar J. Reactive oxygen species (H(2)O(2)): effects on the gallbladder muscle of guinea pigs. Am J Physiol Gastrointest Liver Physiol 2002;282:G300-G306.
128. Xiao ZL, Biancani P, Carey MC, Behar J. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis. HEPATOLOGY 2003;37:1442-1450.
129. Guarino MP, Cong P, Cicala M, Alloni R, Carotti S, Behar J. Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut 2007;56:815-820.
130. Kano M, Shoda J, Irimura T, Ueda T, Iwasaki R, Urasaki T, et al. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones. HEPATOLOGY 1998;28:302-313.
131. Guarino MP, Cong P, Cicala M, Alloni R, Carotti S, Behar J. Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut 2007;56:815-820.
132. Al Jiffry BO, Chen JW, Toouli J, Saccone GT. Endothelins induce gallbladder contraction independent of elevated blood pressure in vivo in the Australian possum. J Gastrointest Surg 2002;6:699-705.
133. Alcon S, Morales S, Camello PJ, Hemming JM, Jennings L, Mawe GM, et al. A redox-based mechanism for the contractile and relaxing effects of NO in the guinea-pig gall bladder. J Physiol 2001;532:793-810.
134. Bird NC, Ahmed R, Chess-Williams R, Johnson AG. Active relaxation of human gallbladder muscle is mediated by ATP-sensitive potassium channels. Digestion 2002;65:220-226.
135. Cullen JJ, Maes EB, Aggrawal S, Conklin JL, Ephgrave KS, Mitros FA. Effect of endotoxin on opossum gallbladder motility: a model of acalculous cholecystitis. Ann Surg 2000;232:202-207.
136. Greaves RR, O'Donnell LJ, Battistini B, Forget MA, Farthing MJ. The differential effect of VIP and PACAP on guinea pig gallbladder in vitro. Eur J Gastroenterol Hepatol 2000;12:1181-1184.
137. Huang SC, Lee MC, Wei CK, Huang SM. Endothelin receptors in human and guinea-pig gallbladder muscle. Regul Pept 2001;98:145-153.
138. Kline LW, Benishin CG, Pang PK. Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) relax cholecystokinin-induced tension in guinea pig gallbladder strips. Regul Pept 2000;91:83-88.
139. Lindaman BA, Hinkhouse MM, Conklin JL, Cullen JJ. The effect of phosphodiesterase inhibition on gallbladder motility in vitro. J Surg Res 2002;105:102-108.
140. Merg AR, Kalinowski SE, Hinkhouse MM, Mitros FA, Ephgrave KS, Cullen JJ. Mechanisms of impaired gallbladder contractile response in chronic acalculous cholecystitis. J Gastrointest Surg 2002;6:432-437.
141. Nissan A, Freund HR, Hanani M. Direct inhibitory effect of erythromycin on human alimentary tract smooth muscle. Am J Surg 2002;183:413-418.
142. Parkman HP, James AN, Thomas RM, Bartula LL, Ryan JP, Myers SI. Effect of indomethacin on gallbladder inflammation and contractility during acute cholecystitis. J Surg Res 2001;96:135-142.
143. Pozo MJ, Perez GJ, Nelson MT, Mawe GM. Ca(2+) sparks and BK currents in gallbladder myocytes: role in CCK-induced response. Am J Physiol Gastrointest Liver Physiol 2002;282:G165-G174.
144. Xiao ZL, Chen Q, Biancani P, Behar J. Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs. Am J Physiol Gastrointest Liver Physiol 2001;281:G490-G497.
145. McKirdy ML, Johnson CD, McKirdy HC. Inflammation impairs neurally mediated responses to electrical field stimulation in isolated strips of human gallbladder muscle. Dig Dis Sci 1994;39:2229-2234.
146. Jazrawi RP, Pazzi P, Petroni ML, Prandini N, Paul C, Adam JA, et al. Postprandial gallbladder motor function: refilling and turnover of bile in health and cholelithiasis. Gastroenterology 1995;109:582-591.
147. Portincasa P, Colecchia A, Di Ciaula A, Larocca A, Muraca M, Palasciano G, et al. Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente. Dig Liver Dis 2000;32:160-172.
148. Everson GT, Braverman DZ, Johnson ML, Kern F Jr. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980;79:40-46.
149. Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990;99:1779-1785.
150. Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985;88:787-791.
151. Palasciano G, Portincasa P, Belfiore A, Baldassarre G, Albano O. Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans. Gastroenterology 1992;102:633-639.
152. Portincasa P, Peeters TL, van Berge-Henegouwen GP, van Solinge WW, Palasciano G, van Erpecum KJ. Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans. Neurogastroenterol Motil 2000;12:421-430.
153. Colecchia A, Sandri L, Bacchi-Reggiani ML, Portincasa P, Palasciano G, Mazzella G, et al. Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting. Am J Gastroenterol 2006;101:2576-2581.
154. Forgacs IC, Murphy GM, Dowling RH. Influence of gallstones and UDCA on gallbladder emptying. Gastroenterology 1984;87:299-307.
155. Venneman NG, Besselink MG, Keulemans YC, vanBerge-Henegouwen GP, Boermeester MA, Broeders IA, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. HEPATOLOGY 2006;43:1276-1283.
156. Guarraci FA, Pozo MJ, Palomares SM, Firth TA, Mawe GM. Opioid agonists inhibit excitatory neurotransmission in ganglia and at the neuromuscular junction in Guinea pig gallbladder. Gastroenterology 2002;122:340-351.
157. Mawe GM. The role of cholecystokinin in ganglionic transmission in the guinea-pig gall-bladder. J Physiol 1991;439:89-102.
158. Mawe GM, Gokin AP, Wells DG. Actions of cholecystokinin and norepinephrine on vagal inputs to ganglion cells in guinea pig gallbladder. Am J Physiol 1994;267:G1146-G1151.
159. Morton MF, Welsh NJ, Tavares IA, Shankley NP. Pharmacological characterization of cholecystokinin receptors mediating contraction of human gallbladder and ascending colon. Regul Pept 2002;105:59-64.
160. Suzuki S, Takiguchi S, Sato N, Kanai S, Kawanami T, Yoshida Y, et al. Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice. Jpn J Physiol 2001;51:585-590.
161. Al Jiffry BO, Meedeniya AC, Chen JW, Toouli J, Saccone GT. Endothelin-1 induces contraction of human and Australian possum gallbladder in vitro. Regul Pept 2001;102:31-39.
162. Al Jiffry BO, Toouli J, Saccone GT. Endothelin-3 induces both human and opossum gallbladder contraction mediated mainly by endothelin-B receptor subtype in vitro. J Gastroenterol Hepatol 2002;17:324-331.
163. Cardozo AM, D'Orleans-Juste P, Bkaily G, Rae GA. Simultaneous changes in intracellular calcium and tension induced by endothelin-1 and sarafotoxin S6c in guinea pig isolated gallbladder: influence of indomethacin. Can J Physiol Pharmacol 2002;80:458-463.
164. Moummi C, Gullikson GW, Gaginella TS. Effect of endothelin-1 on guinea pig gallbladder smooth muscle in vitro. J Pharmacol Exp Ther 1992;260:549-553.
165. Parr E, Pozo MJ, Horowitz B, Nelson MT, Mawe GM. ERG K+ channels modulate the electrical and contractile activities of gallbladder smooth muscle. Am J
166. Wang HH, Portincasa P, Wang HH. Overexpression of esrrogen receptor α (ERα) induces gallbladder hypomotility during cholesterol gallstone formation in mice [Abstract]. Gastroenterology 2007;132:A2.
167. Catnach SM, Fairclough PD, Trembath RC, O'Donnell LJ, McLean AM, Law PA, et al. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992;102:2071-2076.
168. Xu QW, Scott RB, Tan DT, Shaffer EA. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease. HEPATOLOGY 1998;28:613-619.
169. Persson CGA. Adrenoreceptors in the gallbladder. Acta Pharmacol Toxicol 1972;31:177-185.
170. Greaves R, Miller J, O'Donnell L, McLean A, Farthing MJ. Effect of the nitric oxide donor, glyceryl trinitrate, on human gall bladder motility. Gut 1998;42:410-413.
171. McKirdy ML, McKirdy HC, Marshall RW, Lewis MJ. Evidence for the involvement of nitric oxide in the non-adrenergic non-cholinergic relaxation of sphinter muscle strips in vitro. J Physiol (Lond) 1992;446:592P.
172. McKirdy ML, McKirdy HC, Johnson CD. Non-adrenergic non-cholinergic inhibitory innervation shown by electrical field stimulation of isolated strips of human gall bladder muscle. Gut 1994;35:412-416.
173. Kline LW, Karpinski E. Progesterone inhibits gallbladder motility through multiple signaling pathways. Steroids 2005;70:673-679.
174. Gorard DA, Healy JC, O'Donnell LJ, Farthing MJ. Inhibition of 5-hydroxytryptamine re-uptake impairs human gall- bladder emptying. Aliment Pharmacol Ther 1994;8:461-464.
175. Portincasa P, Moschetta A, Di Ciaula A, Palmieri VO, Milella M, Pastore G, et al. Changes of gallbladder and gastric dynamics in patients with acute hepatitis A. Eur J Clin Invest 2001;31:617-622.
176. Fraquelli M, Bardella MT, Peracchi M, Cesana BM, Bianchi PA, Conte D. Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease. Am J Gastroenterol 1999;94:1866-1870.
177. Marciani L, Coleman NS, Dunlop SP, Singh G, Marsden CA, Holmes GK, et al. Gallbladder contraction, gastric emptying and antral motility: Single visit assessment of upper GI function in untreated celiac disease using echo-planar MRI. J Magn Reson Imaging 2005;22:634-638.
178. Gielkens HA, Eddes EH, Vecht J, van Oostayen JA, Lamers CB, Masclee AA. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function. J Hepatol 1997;27:306-312.
179. Mizushima T, Ochi K, Ichimura M, Kiura K, Harada H, Koide N. Pancreatic enzyme supplement improves dysmotility in chronic pancreatitis patients. J Gastroenterol Hepatol 2004;19:1005-1009.
180. Damiao AO, Sipahi AM, Vezozzo DP, Goncalves PL, Fukui P, Laudanna AA. Gallbladder hypokinesia in Crohn's disease. Digestion 1997;58:458-463.
181. Kratzer W, Haenle MM, Mason RA, von TC, Kaechele V. Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease. World J Gastroenterol 2005;11:6170-6175.
182. Masclee AA, Vu MK. Gallbladder motility in inflammatory bowel diseases. Dig Liver Dis 2003;35(Suppl 3):S35-S38.
183. Vu MK, Gielkens HA, van Hogezand RA, van Oostayen JA, Lamers CB, Masclee AA. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection. Scand J Gastroenterol 2000;35:1157-1162.
184. Guliter S, Yilmaz S, Karakan T. Evaluation of gallbladder volume and motility in non-insulin-dependent diabetes mellitus patients using real-time ultrasonography. J Clin Gastroenterol 2003;37:288-291.
185. Hahm JS, Park JY, Park KG, Ahn YH, Lee MH, Park KN. Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol 1996;91:2391-2394.
186. Tasdemir HA, Cetinkaya MC, Polat C, Belet U, Kalayci AG, Akbas S. Gallbladder motility in children with Down syndrome. J Pediatr Gastroenterol Nutr 2004;39:187-191.
187. Moschetta A, Twickler TB, Rehfeld JF, van Ooteghem NA, Cabezas MC, Portincasa P, et al. Effects of growth hormone deficiency and recombinant growth hormone therapy on postprandial gallbladder motility and cholecystokinin release. Dig Dis Sci 2004;49:529-534.
188. Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut 2003;52:109-115.
189. Kamath PS, Gaisano HY, Phillips SF, Miller LJ, Charboneau JW, Brown ML, et al. Abnormal gallbladder motility in irritable bowel syndrome: evidence for target-organ defect. Am J Physiol 1991;260:G815-G819.
190. Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003;9:2293-2299.
191. Nakeeb A, Comuzzie AG, Al Azzawi H, Sonnenberg GE, Kissebah AH, Pitt HA. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg 2006;10:940-948.
192. Acalovschi M, Dumitrascu DL, Csakany I. Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis - a simultaneous sonographic study. Gut 1997;40:412-417.
193. Acalovschi M, Dumitrascu DL, Nicoara CD. Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones. Dig Dis Sci 2004;49:17-24.
194. Dumitrascu DL, Acalovschi M. Impaired gallbladder motility in liver cirrhosis: yes, but. . . Am J Gastroenterol 2000;95:3650-3651.
195. Portincasa P, Di Ciaula A, Palmieri VO, vanBerge-Henegouwen GP, Palasciano G. Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects. Eur J Clin Invest 1995;25:746-753.
196. Sari R, Balci MK, Coban E, Karayalcin U. Sonographic evaluation of gallbladder volume and ejection fraction in obese women without gallstones. J Clin Ultrasound 2003;31:352-357.
197. Zapata R, Severin C, Manriquez M, Valdivieso V. Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss. Dig Dis Sci 2000;45:421-428.
198. Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, et al. Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 1992;117:711-718.
199. Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, et al. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients-a clinical research center study. J Clin Endocrinol Metab 1995;80:2768-2775.
200. Redfern JS, Fortuner WJ. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management. Am J Gastroenterol 1995;90:1042-1052.
201. Portincasa P, DiCiaula A, Palmieri V, Velardi A, van Berge-Henegouwen GP, Palasciano G. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Ital J Gastroenterol 1996;28:111-113.
202. van Erpecum KJ, van Berge Henegouwen GP, Stolk MF, Hopman WP, Jansen JB, Lamers CB. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. Gastroenterology 1990;99:836-842.
203. Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992;21:751-776.
204. Radberg G, Asztely M, Cantor P, Rehfeld JF, Jarnfeldt Samsioe A, Svanvik J. Gastric and gallbladder emptying in relation to the secretion of cholecystokinin after a meal in late pregnancy. Digestion 1989;42:174-180.
205. Thijs C, Knipschild P, Leffers P. Pregnancy and gallstone disease: an empiric demonstration of the importance of specification of risk periods. Am J Epidemiol 1991;134:186-195.
206. Van Bodegraven AA, Bohmer CJ, Manoliu RA, Paalman E, Van der Klis AH, Roex AJ, et al. Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol 1998;33:993-997.
207. van de Meeberg PC, Portincasa P, Wolfhagen FH, van Erpecum KJ, vanBerge-Henegouwen GP. Increased gall bladder volume in primary sclerosing cholangitis. Gut 1996;39:594-599.
208. Snow ND, Liddle RA. Neuroendocrine Tumors. In: Rustgi AK, ed. Gastrointestinal Cancers: Biology, Diagnosis and Therapy. Philadelphia, PA: Lippincott-Raven; 1995:585.
209. Apstein MD, Dalecki-Chipperfield K. Spinal cord injury is a risk factor for gallstone disease. Gastroenterology 1987;92:966-968.
210. Tandon RK, Jain RK, Garg PK. Increased incidence of biliary sludge and normal gallbladder contractility in patients with high spinal cord injury. Gut 1997;41:682-687.
211. Kalayci AG, Albayrak D, Gunes M, Incesu L, Agac R. The incidence of gallbladder stones and gallbladder function in beta-thalassemic children. Acta Radiol 1999;40:440-443.
212. Cano N, Cicero F, Ranieri F, Martin J, di Costanzo J. Ultrasonographic study of gallbladder motility during total parenteral nutrition. Gastroenterology 1986;91:313-317.
213. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990;170:25-31.
214. Portincasa P, Altomare DF, Moschetta A, Baldassarre G, Di Ciaula A, Venneman NG, et al. The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study. Am J Gastroenterol 2000;95:3444-3451.
215. Takahashi T, Yamamura T, Yokoyama E, Kantoh M, Kusunoki M, Ishikawa Y, et al. Impaired contractile motility of the gallbladder after gastrectomy. Am J Gastroenterol 1986;81:672-677.
216. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 2005;25:2243-2244.